Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Lancet 402(10402):613626 Wadden TA, Chao AM, Machineni S et al (2023) Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial
Our program focuses on restoring metabolic balance, improving body composition, and helping you feel like yourself again physically, mentally, and hormonally
"Obesity affects approximately 17 million adults in Korea and increases the risk of over 200 complications, including type 2 diabetes and cardiovascular diseases, Korean Society for the Study of Obesity President Park Cheol-yeong said
Tirzepatide generally produces greater weight loss than semaglutide at equivalent time points
Data availability The review data will be shared upon request from the corresponding author
Antiinflammatory actions of GLP-1 medicines across organs
US$ 24.28
US$ 27.18
US$ 20.20
US$ 20.19
